Palvella Therapeutics Inc (PVLA)
NASDAQ
Fin d'année 31 Décembre 2023 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Return on Assets (%) | -1.46 | -69.086 | -77.894 | -101.375 |
Return on Equity (%) | -8.333 | -76.181 | -87.681 | -124.726 |
Return on Invested Capital (%) | 1.77 | -75.901 | -56.169 | -128.107 |
Operating Margin (%) | N/A | -1605.379 | -1105.237 | -1880.67 |
Net Profit Margin (%) | N/A | -1606.069 | -1078.523 | -1880.784 |
Book Value Per Share | 0.002 | 1.366 | 0.744 | 1.03 |
Earnings Per Share | N/A | -0.52 | -0.933 | -2.912 |
Cash Per Share | N/A | 1.386 | 0.209 | 0.583 |
Working Capital Per Share | -0.008 | 1.418 | 0.704 | 0.922 |
Operating Profit Per Share | N/A | 0.011 | 0.026 | 0.098 |
EBIT Per Share | N/A | -0.52 | -0.956 | -2.911 |
EBITDA Per Share | N/A | -0.52 | -0.956 | -2.911 |
Free Cash Flow Per Share | N/A | -0.494 | -0.945 | -3.034 |
Fin d'année 31 Décembre 2023 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A |
Actions en circulation | 6,9M | 142,85M | N/A | 25,9M |
Fin d'année 31 Décembre 2023 | Déc 2022 | Mar 2023 | Juin 2023 | Sept 2023 | Déc 2023 | Mar 2024 | Juin 2024 | Sept 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | |||||
Actions en circulation | N/A | N/A | N/A | N/A | 25,9M | N/A | N/A | N/A |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | N/A | -935.366 | N/A | N/A | N/A | -210.084 | N/A | N/A |
Net Profit Margin (%) | N/A | -935.366 | N/A | N/A | N/A | -210.084 | N/A | N/A |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Capitalisation boursière | 18,34M |
Ratio cours/bénéfice | -0,16 |
Ratio prix/ventes | 2,98 |
Ratio prix/liquidités | 0,79 |
Ratio prix/valeur comptable | 0,45 |
Rendement de dividende | - |
Actions en circulation | 1,32M |
Volume moyen (1 semaine) | 36,99k |
Volume moyen (1 mois) | 34,22k |
Variation sur 52 semaines | 1,83% |
Plus haut sur 52 semaines | 15,67 |
Plus bas sur 52 semaines | 11,10 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales